Markman on Oncology

• 'Remarkably Distressing': 35% of US Population Obese   The state of obesity 2018: Dr Maurie Markman discusses sobering statistics demonstrating this serious public health problem in the United States.
  Medscape Oncology, December 20, 2018
• 'Shocking' Results With Minimally Invasive Hysterectomy   The surprising results of two new studies prompt a warning from Dr Maurie Markman that minimally invasive radical hysterectomy should not be considered standard of care for early cervical cancer.
  Medscape Oncology, November 15, 2018
• Conflicting Meta-analyses Put 'Intellectual COI' Front and Center   There are multiple kinds of conflicts of interest that may bias research, argues Dr Maurie Markman.
  Medscape Oncology, October 24, 2018
• Lack of Transparency Eroding Public Trust in Cancer Medicine   Research and development are necessary to help patients with cancer, but conflicts of interest should be clearly stated. We need to 'ensure transparency and truth,' says Dr Maurie Markman.
  Medscape Oncology, October 05, 2018
• Local Radiation May Improve Survival in Metastatic Cervical Cancer   This new analysis found a significant survival advantage with chemoradiation compared with chemotherapy alone, even in metastatic disease.
  Medscape Oncology, September 17, 2018
• Study: Surgeons Report Optimal Residual Disease Incorrectly in 40% of Cases   Dr Maurie Markman discusses a 'concerning' trial demonstrating a significant difference between surgical and radiographic assessments of residual disease in patients with advanced ovarian cancer.
  Medscape Oncology, August 21, 2018
• New RCT Favors Standard of Care for Squamous Cervical Cancer   Neoadjuvant chemotherapy falls short of chemoradiation in this new study.
  Medscape Oncology, July 30, 2018
• Trastuzumab Increases PFS in Women With HER2/neu Uterine Cancer   This well-done study should prompt oncologists to consider adding trastuzumab to carboplatin-paclitaxel treatment for women with advanced HER2/neu-positive uterine cancer, says Dr Maurie Markman.
  Medscape Oncology, July 13, 2018
• HPV Vaccine's 'Extraordinary Benefits' Seen in Cochrane Review   All involved with the health of young women should read the 'extremely important' results of the latest Cochrane review on HPV vaccination, says Dr Maurie Markman.
  Medscape Oncology, June 07, 2018
• ASCO 2018 Gynecologic Cancer Studies to Look For at ASCO 2018   Dr Maurie Markman highlights the gynecologic cancer studies to watch for at ASCO 2018.
  Medscape Oncology, May 24, 2018
• Is This 'Provocative Finding' Related to Serous Ovarian Cancer?   Dr Maurie Markman discusses a provocative new study on BRCA1 methylation status and ovarian cancer.
  Medscape Oncology, May 09, 2018
• Oncologists Spend Too Little Time With Patients, Too Much on EHR   The Medscape Oncologist Compensation Report 2018 reveals more about oncology practice than simple dollars and cents.
  Medscape Oncology, April 26, 2018
• 'Clear Role' for PARP Inhibitors in Advanced Ovarian Cancer   Recent approval of rucaparib gives patients with ovarian cancer another new option for maintenance therapy.
  Medscape Oncology, April 17, 2018
• Stop Screening for Early Ovarian Cancer, USPSTF Says   There is no evidence that screening actually improves outcomes in ovarian cancer, according to a USPSTF analysis of the best available data.
  Medscape Oncology, April 13, 2018
• FDA Again Advises Against Morcellators for Fibroids   The risk for uterine sarcoma being found in fibroids is too high, notes Dr Markman.
  Medscape Oncology, February 08, 2018
• Oral HPV Infection Rate Is Alarmingly High in US Men   A large population-based study argues for more rigorous efforts to vaccinate against HPV infection and prevent subsequent head and neck cancers, says Dr Markman.
  Medscape Oncology, January 25, 2018
• Oncologists Need to Encourage Their Patients to Exercise   Even a brief conversation about exercise can reap significant health benefits to patients, argues Dr Markman.
  Medscape Oncology, December 18, 2017
• An Urgent Plea to Oncologists for HPV Vaccination   Oncologists fail to recommend HPV vaccination to young cancer survivors, even though it is a safe and effective cancer prevention strategy.
  Medscape Oncology, November 02, 2017
• Mitigating Side Effects to Reach PARP Inhibitors' Potential   Low-grade nausea could lead women to skip or lower the dose of these agents, says Dr Markman.
  Medscape Oncology, October 13, 2017
• Pembrolizumab, Larotrectinib Point to Future of Precision Medicine   With the examples of pembrolizumab and larotrectinib, Dr Markman discusses how precision cancer medicine will likely change the landscape of cancer therapy.
  Medscape Oncology, August 08, 2017